细胞因子IL-7的基础与临床研究进展(3)
参考文献
[1] Alpdogan O, vanden B rink MR. IL-7 and IL-15: Therapeutic cytokines for immunodeficiency[J]. Trends I mmunol.2005, 26 (1) : 56-64
[2] Dus D,Krawczenko A,Zalecki P,et al.IL-7 receptor is presenton human microvscular endothelial cells[J]Immunology Leters,2003,86:163-168
[3] Xie ML,Wu YG.GM-CSF and IFN—induced expression of human leucocyte antigen class 2 molecules on basophils of umbilical cord blood[J].Acta Pharmacol Sin,2002,23:645
, http://www.100md.com
[4] Kondo M， Scherer D C， Miyamoto T， et al. Cell-fate conversion of lymphoid-committed progenitors by in-structive actions of cytokines[J]. Nature，2008，407：383-386
[5] Six E M， Bonhomme D， Monteiro M， et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus[J]. J Exp Med，2007，204：3085-3093
[6] Milne CD, Paige C J. IL7 : A key regulator of B lymphopoi esis[J].Semin Immunol 2006, 18(1) : 20-30
, 百拇医药
[7] Kikuchi K，Lai A Y，Hsu C L，et al. IL-7 receptor signaling is necessary for stage transition in adult B celldevelopment through up-regulation of EBF[J]. J Exp Med，2007，201：1197-1203
[8] Kikuchi K，Kasai H，Watanabe A，et al. IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression[J]. J Immunol，2008，181：383-392
[9] Scheeren F A，Naspetti M，Diehl S，et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression[J]. Nat Immunol，2007，6：303-313.
, 百拇医药
[10] LuH, Zhao Z, Kalina T, et al. Interleukin-7 improves reconstitution of anti viral CD4 T cells. Clin Immunol,2005, 114 (1) : 30-41。
[11] Mackarehtschian K，Hardin J D，Moore K A，et al. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors[J]. Immunity，2007，3：147-161
[12] Salopek D，Grcevi？ D， Katavi？ V， et al. Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter[J]. Immunol Lett，2008，121：134-139
, 百拇医药
[13] Li A,Zhang Q, Jiang J, et al. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.Gene Ther. 2006 ;13(15):1178-87
[14] LiAL, L iC, Feng YG, e t a l. Antileukemic effect of interleuk in-7 transduced bonem arrow stomal cells in mice following allogeneic T cell deplleted bone marrow transplantation[J]. Trans plant P, 2005,37(5) : 2297-2299
, http://www.100md.com
[15] Managlia EZ, Landay A. Interleuk in-7 signalling is sufficient to phenotypi cally and functionally prime human CD4 naive T cells[J]. Immunol.2005, 114 (3) : 322-335
[16] Rosenberg SA, Sportes C, Ahmadzadeh M, eta l. I L-7 administrationto humans leads to expansion of CD8+and CD4+cells but a relative decrease of CD4+T-regulatory cells. J Immunother, 2006, 29 (3) :313-319.。
[17] Sasson SC, Zaunders JJ, Zanetti G, et al. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis. 2006,15;193(4):505-14
, 百拇医药
[18] .Schmitt N,Chene L,Boutolleau D,ET AL.positive regulation of expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virys replication[J].J Virol,2003,77(10):5784-5793
[19] Zaunders JJ, M un ierML, Kaufmann DE, et al. Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection. Blood, 2005, 106(5) : 1660-1667
, http://www.100md.com
[20] Paiardini M, Cervasi B, AlbrechtH, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.. J Immunol 2005, 174(5): 2900-2909
[21] M anaglia EZ, Landay A, A l tarth iL, et a l. Interl eukin-7 induces H I V replication in primary na？ve T cells through a nuclear factor of activatedT cell (NF AT) dependent pathway [J]. V irology, 2006, 350 (2) :443-452
[22] Claude Sportès，Crystal L. Mackall, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, Experimental Medicine，2008. 205：1701-1714
, 百拇医药
[23] H offjan S, B eygo J, A kk ad DA, et a l. Analysis of variation in the IL-7RA and IL-2RA genesin atopicder matitis[J]. J Der matol Sci.2009, 55(2) : 123-141
[24] Fri da L, Kristi n a D, AnH, e ta l. Genet i c associ ation anal ysis of the Interleukin-7 gene (IL-7) i nmultiplescleros is [J]. JNeu Iuoimmunol.2007, 192(1-2) : 171-173
[25] Sasson SC, Zaunders JJ, Kelleher AD.The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets. 2006 ;7(12):1571-82, http://www.100md.com(刘道华 赖璟妍 夏德林)
[1] Alpdogan O, vanden B rink MR. IL-7 and IL-15: Therapeutic cytokines for immunodeficiency[J]. Trends I mmunol.2005, 26 (1) : 56-64
[2] Dus D,Krawczenko A,Zalecki P,et al.IL-7 receptor is presenton human microvscular endothelial cells[J]Immunology Leters,2003,86:163-168
[3] Xie ML,Wu YG.GM-CSF and IFN—induced expression of human leucocyte antigen class 2 molecules on basophils of umbilical cord blood[J].Acta Pharmacol Sin,2002,23:645
, http://www.100md.com
[4] Kondo M， Scherer D C， Miyamoto T， et al. Cell-fate conversion of lymphoid-committed progenitors by in-structive actions of cytokines[J]. Nature，2008，407：383-386
[5] Six E M， Bonhomme D， Monteiro M， et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus[J]. J Exp Med，2007，204：3085-3093
[6] Milne CD, Paige C J. IL7 : A key regulator of B lymphopoi esis[J].Semin Immunol 2006, 18(1) : 20-30
, 百拇医药
[7] Kikuchi K，Lai A Y，Hsu C L，et al. IL-7 receptor signaling is necessary for stage transition in adult B celldevelopment through up-regulation of EBF[J]. J Exp Med，2007，201：1197-1203
[8] Kikuchi K，Kasai H，Watanabe A，et al. IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression[J]. J Immunol，2008，181：383-392
[9] Scheeren F A，Naspetti M，Diehl S，et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression[J]. Nat Immunol，2007，6：303-313.
, 百拇医药
[10] LuH, Zhao Z, Kalina T, et al. Interleukin-7 improves reconstitution of anti viral CD4 T cells. Clin Immunol,2005, 114 (1) : 30-41。
[11] Mackarehtschian K，Hardin J D，Moore K A，et al. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors[J]. Immunity，2007，3：147-161
[12] Salopek D，Grcevi？ D， Katavi？ V， et al. Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter[J]. Immunol Lett，2008，121：134-139
, 百拇医药
[13] Li A,Zhang Q, Jiang J, et al. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.Gene Ther. 2006 ;13(15):1178-87
[14] LiAL, L iC, Feng YG, e t a l. Antileukemic effect of interleuk in-7 transduced bonem arrow stomal cells in mice following allogeneic T cell deplleted bone marrow transplantation[J]. Trans plant P, 2005,37(5) : 2297-2299
, http://www.100md.com
[15] Managlia EZ, Landay A. Interleuk in-7 signalling is sufficient to phenotypi cally and functionally prime human CD4 naive T cells[J]. Immunol.2005, 114 (3) : 322-335
[16] Rosenberg SA, Sportes C, Ahmadzadeh M, eta l. I L-7 administrationto humans leads to expansion of CD8+and CD4+cells but a relative decrease of CD4+T-regulatory cells. J Immunother, 2006, 29 (3) :313-319.。
[17] Sasson SC, Zaunders JJ, Zanetti G, et al. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis. 2006,15;193(4):505-14
, 百拇医药
[18] .Schmitt N,Chene L,Boutolleau D,ET AL.positive regulation of expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virys replication[J].J Virol,2003,77(10):5784-5793
[19] Zaunders JJ, M un ierML, Kaufmann DE, et al. Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection. Blood, 2005, 106(5) : 1660-1667
, http://www.100md.com
[20] Paiardini M, Cervasi B, AlbrechtH, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.. J Immunol 2005, 174(5): 2900-2909
[21] M anaglia EZ, Landay A, A l tarth iL, et a l. Interl eukin-7 induces H I V replication in primary na？ve T cells through a nuclear factor of activatedT cell (NF AT) dependent pathway [J]. V irology, 2006, 350 (2) :443-452
[22] Claude Sportès，Crystal L. Mackall, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, Experimental Medicine，2008. 205：1701-1714
, 百拇医药
[23] H offjan S, B eygo J, A kk ad DA, et a l. Analysis of variation in the IL-7RA and IL-2RA genesin atopicder matitis[J]. J Der matol Sci.2009, 55(2) : 123-141
[24] Fri da L, Kristi n a D, AnH, e ta l. Genet i c associ ation anal ysis of the Interleukin-7 gene (IL-7) i nmultiplescleros is [J]. JNeu Iuoimmunol.2007, 192(1-2) : 171-173
[25] Sasson SC, Zaunders JJ, Kelleher AD.The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets. 2006 ;7(12):1571-82, http://www.100md.com(刘道华 赖璟妍 夏德林)